학술논문

Real-World Evidence of Ribociclib Plus Aromatase Inhibitors as First-Line Treatment in Advanced Breast Cancer: The BrasiLEEira Study
Document Type
Article
Source
In: JCO Global Oncology. (JCO Global Oncology, 2024, 10)
Subject
Language
English
ISSN
26878941